Innovotech Announces Grant of Stock Options
January 23 2014 - 2:43PM
Marketwired
Innovotech Announces Grant of Stock Options
EDMONTON, ALBERTA--(Marketwired - Jan 23, 2014) - Innovotech
Inc. (TSX-VENTURE:IOT) ("Innovotech") today announced that, in
accordance with the policies of the TSX Venture Exchange, the board
of directors has approved a grant of stock options to management of
Innovotech to purchase 50,000 common shares pursuant to its stock
option plan. These options have an exercise price of $0.045 per
common share and expire on January 22, 2024.
About Innovotech Inc:
Innovotech Inc. is an innovator in the field of biofilm
product development, focused on providing innovative and practical
solutions to medical, agricultural and industrial problems caused
by microbial biofilms. Biofilms are organized communities of
microorganisms that exist in virtually every natural environment
and are responsible for a host of diseases in human health, animal
health and agriculture. There are few products or regulatory
standards, aside from those of Innovotech, designed specifically
for biofilm-forming organisms.
Innovotech has a range of products that address the issue of
biofilms within a number of different industries, including
commercially available products in a variety of market segments;
the MBEC Assay™, InnovoSIL™, bioFILM PA™, InnovoSCEPT™-Human and
InnovoSCEPT™-Veterinary tests. The MBEC Assay™ is a high throughput
biofilm growth device that is an ASTM International standard.
InnovoSIL™ is a family of silver-based antimicrobials promising
superior performance for medical device coatings and wound
dressings, bioFILM PA™ and InnovoSCEPT™-Human are the first
diagnostic tests to assist physicians in the selection of the most
effective antibiotic treatment for patients with biofilm-based
chronic infections, while the InnovoSCEPT™-Veterinary tests are
designed to determine the most effective antibiotic treatment for
chronic infections in both large and small animals.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Innovotech Inc.Dr. James TimourianPresident780.448.0585 ext
221james.timourian@innovotech.cawww.innovotech.ca
Innovotech (TSXV:IOT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Innovotech (TSXV:IOT)
Historical Stock Chart
From Nov 2023 to Nov 2024
